Körver, Simon http://orcid.org/0000-0003-1432-7760
Geurtsen, Gert J.
Hollak, Carla E. M.
van Schaik, Ivo N.
Longo, Maria G. F.
Lima, Marjana R.
Vedolin, Leonardo
Dijkgraaf, Marcel G. W.
Langeveld, Mirjam
Funding for this research was provided by:
Academisch Medisch Centrum (innovation grant 2014)
Article History
Received: 15 July 2019
Accepted: 14 January 2020
First Online: 28 January 2020
Ethics approval and consent to participate
: This study was approved by the Human Research Ethics Committee of the AMC (2016_060) and conducted in accordance with the Declaration of Helsinki of 2013 [CitationRef removed]. All participants provided informed consent prior to inclusion.
: Not applicable.
: SK, GJG, MGFL, MRL, LV and MGWD report no competing interests. CEMH and ML are involved in pre-marketing studies with Genzyme, Protalix and Idorsia. Financial arrangements are made through AMC Research BV. No fees, travel support or grants are obtained from Pharmaceutical Industries. They report no non-financial competing interests. INS chairs a steering committee for CSL Behring and received departmental honoraria for serving on scientific advisory boards for CSL Behring and Baxter. All lecturing and consulting fees for INS were donated to the Stichting Klinische Neurologie, a local foundation that supports research in the field of neurological disorders. He reports no non-financial competing interests.